Peritoneal Cancer clinical trials

Explore recruiting peritoneal cancer clinical trials.

Recruiting peritoneal cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Peritoneal Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Metronomic neoadjuvant capecitabine and cyclophosphamide in huge (PCI>28) Pseudomyxoma peritonei (PMP) patients candidates to cytoreductive surgery (CRS) and hypertermic intraperitoneal chemotherapy (HIPEC).

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

5-Aminolevulinic Acid (5-ALA) for Intraoperative Imaging in Patients with Ovarian Cancer – a Single Center Feasibility Study (ILLUMINATE)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Prospective, non randomized, Phase II study on MK-3475 in recurrent, platinum-resistant, CPS ≥1 positive ovarian, Fallopian tube and primary peritoneal cancer patients

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomised, double-blind, parallel group, placebo-controlled multi-centre Phase III study to assess the efficacy and safety of olaparib versus placebo as adjuvant treatment in patients with germline BRCA1/2 mutations and high risk HER2 negative primary breast cancer who have completed definitive local treatment and neoadjuvant or adjuvant chemotherapy.

Spain, Iceland, Sweden, Netherlands, Poland, Germany +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

BRCA-P: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, International Phase 3 Study to Determine the Preventive Effect of Denosumab on Breast Cancer in Women Carrying a BRCA1 Germline Mutation

Spain, Germany, Austria

Therapeutic confirmatory (Phase III) EU CTIS Study details

Neo-adjuvant intraperitoneal chemotherapy (irinotecan) and systemic chemotherapy (mFOLFOX4-bevacizumab) prior to CRS-HIPEC for patients with isolated resectable colorectal peritoneal metastases: a multicentre, phase II trial (INTERACT-PLUS)

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Peritoneal Cancer trials by city

Peritoneal Cancer in Toronto Peritoneal Cancer in Vancouver Peritoneal Cancer in Montreal Peritoneal Cancer in Calgary Peritoneal Cancer in Edmonton Peritoneal Cancer in Ottawa Peritoneal Cancer in Winnipeg Peritoneal Cancer in Quebec City Peritoneal Cancer in Hamilton Peritoneal Cancer in Kitchener Peritoneal Cancer in London Peritoneal Cancer in Halifax Peritoneal Cancer in New York Peritoneal Cancer in Los Angeles Peritoneal Cancer in Chicago Peritoneal Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease